Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: Delorbis Pharmaceuticals Ltd., 17 Athinon Street, Ergates Industrial Area, 2643 Ergates, P.O. Box 28629, 2081 Lefkosia, Cyprus, European Union
Cleron 250 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablets. Cleron 250 mg film-coated tablets are yellow, round, concave film-coated tablets, 12 mm in diameter, scored on one side and embossed with “CLERON 250”. |
Each film-coated tablet contains 250 mg of clarithromycin.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Clarithromycin |
Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria. |
| List of Excipients |
|---|
|
Povidone, sodium starch glycolate, microcrystalline cellulose, starch, crospovidone, stearic acid, magnesium stearate, talc, colloidal silicon dioxide. Coating: opadry, quinoline yellow lake. |
PVC/Al blister strips: 7 tablets and 14 tablets.
Not all pack sizes may be marketed.
Delorbis Pharmaceuticals Ltd., 17 Athinon Street, Ergates Industrial Area, 2643 Ergates, P.O. Box 28629, 2081 Lefkosia, Cyprus, European Union
018052
Date of first authorization: 30 November 1998
| Drug | Countries | |
|---|---|---|
| CLERON | Cyprus, Hong Kong, Malta, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
